Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC

Summary

This is a prospective, randomized, single clinical study designed to evaluate its safety and efficacy by using Microwave Ablation combine with Pembrolizumab in patients with Stage ⅢB-Ⅳ Non-small Cell Lung.Cancer (NSCLC) who failed with first-line therapy.

Timeline

Start

2018-11-01

Primary completion

2026-11-01

Completion

2029-11-01

Drugs

Indications